Fcepsilonri-beta gene: identification of regulatory elements and analysis of the effect of genetic variability.

Project Information

MAURO D'AMATO

Grant agreement ID: QLK4-CT-2000-52121

Project closed

Start date 25 April 2001

End date 24 April 2003

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 114 272,00

EU contribution € 114 272,00

Coordinated by

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

Objective

FcepsilonRI-beta gene confers susceptibility to asthma and allergy. However, it is not known how gene expression is regulated, what are the controlling elements and what the actions of genetic variants in inducing disease. The elucidation of these mechanisms represents the final goal of the project.

Fields of science

• medical and health sciences › clinical medicine › pneumology › asthma
• medical and health sciences › clinical medicine › allergology

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-4. - Key action Environment and Health

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

• EU contribution: No data
• Address: Roosevelt Drive ; OX3 7BN OXFORD/HEADINGTON ; United Kingdom
• Total cost: No data